Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Antiviral Agents for Nonhospitalized Patients With COVID-19

Hear expert insights on the use of IV and oral antiviral agents for the treatment of nonhospitalized patients with COVID-19.
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: January 6, 2022

Information on this Educational Activity

Faculty

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
Melbourne, Australia

Sharon R. Lewin, AO, FRACP, PhD, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

Clinical Care Options (CCO) module with insights from Dr. Michael Ison on SARS-CoV-2 antivirals and monoclonal antibodies for outpatient treatment

person default Michael G. Ison, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 25, 2022 Expired: May 24, 2023

Download slides reviewing the latest data and guidance on COVID-19 vaccinations, including authorized and investigational agents, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 24, 2022

Prof Cristina Mussini discusses new data from ECCMID 2022 on COVID-19 treatments, vaccination, and long COVID, from Clinical Care Options (CCO)

Cristina Mussini, MD Released: May 23, 2022

Dr Kristen Marks on COVID-19 second booster dose: indication, which vaccine, and timing, from Clinical Care Options (CCO)

Kristen Marks, MD Released: May 20, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings